US · BMRA
Biomerica, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Irvine, CA 92614
- Website
- biomerica.com
Price · as of 2025-05-31
$2.19
Market cap 6.28M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $185.60 | +8,374.89% |
| Intrinsic Value(DCF) | $1.24 | -43.38% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | $5.28 | $0.14 | $1.12 | $2.15 | |
| 2013 | $7.28 | $81.28 | $0.27 | $1.21 | $1.09 |
| 2014 | $7.04 | $352.95 | $0.19 | $0.67 | $0.35 |
| 2015 | $6.64 | $106.70 | $0.12 | $0.52 | $0.00 |
| 2016 | $19.60 | $115.97 | $0.08 | $0.00 | $0.00 |
| 2017 | $21.76 | $74.40 | $0.00 | $0.00 | $0.00 |
| 2018 | $30.32 | $35.12 | $0.00 | $0.00 | $0.00 |
| 2019 | $27.68 | $38.80 | $0.00 | $0.00 | $0.00 |
| 2020 | $70.48 | $62.23 | $0.57 | $0.25 | $0.00 |
| 2021 | $31.52 | $32.41 | $0.00 | $0.00 | $0.00 |
| 2022 | $25.44 | $128.59 | $2,106.68 | $0.00 | $0.00 |
| 2023 | $10.08 | $56.19 | $7.40 | $0.00 | $30.54 |
| 2024 | $2.64 | $26.83 | $1.53 | $0.00 | $0.00 |
| 2025 | $3.11 | $185.60 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Biomerica, Inc.'s (BMRA) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $185.60
- Current price
- $2.19
- AI upside
- +8,374.89%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.24
-43.38% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| BMRA | Biomerica, Inc. | $2.19 | 6.28M | +8,375% | -43% | — | — | -1.44 | 1.74 | 1.35 | -1.10 | -0.29 | 1.84 | 9.38% | -96.72% | -93.64% | -92.99% | -191.32% | -65.44% | 0.11 | — | 2.80 | 1.80 | 0.41 | 50000.00% | -192.00% | -2918.00% | -54.28% | -2.21 | -144.43% | 0.00% | 0.00% | 0.00% | -1.01 | -1.34 | 0.98 | -11.52 |
| ALZN | Alzamend Neuro, Inc. | $2.01 | 6.31M | — | — | — | — | -0.28 | 0.32 | — | 0.60 | — | 0.32 | 0.00% | — | — | -657.17% | 339.39% | -172.50% | 0.00 | -249.42 | 6.58 | 6.22 | 0.89 | -9145.00% | — | -1840.00% | -539.27% | -10.35 | 518.36% | 0.00% | 0.00% | 304.12% | 0.59 | 0.39 | — | -18.90 |
| CELZ | Creative Medical Technolo… | $1.81 | 4.67M | +18,729% | +39% | — | — | -1.12 | 0.97 | 558.52 | -0.04 | — | 1.06 | 60.00% | -52216.92% | -49940.74% | -65.85% | -1515.86% | -63.20% | 0.00 | — | 18.73 | 18.13 | 1.05 | -133.00% | 2222.00% | -3478.00% | -86.29% | -16.18 | -1399.06% | 0.00% | 0.00% | 43.11% | -0.04 | -0.04 | 18.49 | -4.10 |
| HSCS | HeartSciences Inc. | $2.79 | 6.25M | +699% | -40% | — | +21,742% | -0.45 | 19.02 | 897.28 | -0.71 | — | -2.77 | -2884.71% | -192013.13% | -201499.52% | -233.04% | -360.16% | -127.72% | 14.55 | -16.69 | 0.59 | 0.30 | -0.23 | -5016.00% | -7661.00% | 2014.00% | -190.70% | -2.00 | -320.95% | 0.00% | 0.00% | 0.00% | -0.69 | -0.78 | 1331.10 | -31.62 |
| IINN | Inspira Technologies Oxy … | $0.58 | 13.97M | — | — | — | — | -1.42 | 3.64 | — | -1121.82 | — | 3.64 | 0.00% | — | — | -219.74% | 7.39% | -127.19% | 0.58 | — | 2.02 | 1.71 | 234.68 | -9994.00% | — | -426.00% | -60.68% | -2.78 | -6254.43% | 0.00% | 0.00% | 0.00% | 1104.79 | -1.31 | — | -8.52 |
| LFWD | Lifeward Ltd. | $7.40 | 11.28M | +6% | +25,985% | — | — | -0.49 | 0.75 | 0.55 | -0.32 | -1.71 | 1.25 | 32.01% | -76.19% | -112.78% | -88.56% | -118.09% | -61.79% | 0.05 | -152.76 | 2.08 | 1.27 | 0.24 | 2857.00% | 8524.00% | 468.00% | -153.36% | -2.12 | -131.16% | 0.00% | 0.00% | 0.00% | -0.41 | -0.37 | 0.32 | -12.27 |
| LUCY | Innovative Eyewear, Inc. | $1.12 | 5.12M | +2,253% | +40,227,901% | — | — | -0.81 | 0.69 | 3.84 | 0.16 | — | 0.73 | 13.15% | -484.20% | -474.60% | -106.00% | -557.55% | -96.74% | 0.00 | — | 12.52 | 10.38 | 0.35 | -5904.00% | 4199.00% | 1643.00% | -111.49% | -9.14 | -493.01% | 0.00% | 0.00% | 0.00% | 0.16 | 0.18 | -0.76 | 0.10 |
| PAVM | PAVmed Inc. | $10.08 | 5.41M | +10,627% | +918% | +5,945% | +35,854% | 0.23 | -2.66 | 2.21 | 1.26 | — | -2.66 | -101.60% | -1485.38% | 1328.58% | -100.94% | -2590.22% | 89.14% | -12.77 | -988.60 | 0.06 | 0.03 | 1.03 | -10541.00% | 2215.00% | -3571.00% | -507.27% | -0.95 | -1956.86% | 0.00% | 0.00% | 0.00% | -0.84 | -1.11 | 12.45 | -17.53 |
| PTHL | Pheton Holdings Ltd Class… | $0.36 | 5.23M | +20,678% | +219% | -37% | +178% | -44.29 | 4.73 | 65.28 | -39.57 | -20.83 | 4.73 | 85.04% | -171.80% | -147.48% | -20.35% | -297.84% | -15.84% | 0.04 | — | 12.40 | 12.01 | 10.02 | 21265.00% | -2870.00% | 111922.00% | -2.65% | -1.44 | -300.11% | 0.00% | 0.00% | 19.99% | -30.32 | -30.09 | 52.09 | 33.27 |
| SINT | Sintx Technologies, Inc. | $2.89 | 7.97M | +19,466% | -54% | — | +21,505% | -0.22 | 0.63 | 1.98 | -0.30 | — | 0.64 | 34.91% | -1127.37% | -884.75% | -174.07% | -193.62% | -88.98% | 1.03 | -484.38 | 2.41 | 1.91 | -0.04 | -2178.00% | -5257.00% | -3628.00% | -378.55% | -4.36 | -128.63% | 0.00% | 0.00% | 40.16% | -0.21 | -0.31 | 2.32 | -46.07 |
| SSKN | STRATA Skin Sciences, Inc… | $0.21 | 892.55K | +26,438% | +386% | — | — | -9.66 | 19.60 | 2.90 | -37.52 | — | -32.12 | 56.85% | -27.58% | -30.05% | -114.22% | -51.01% | -25.80% | 3.31 | -4.39 | 1.13 | 0.86 | -3.23 | -1613.00% | 61.00% | -7385.00% | -1.49% | 0.01 | -8.11% | 0.00% | 0.00% | 0.00% | -11.52 | -73.65 | 3.18 | -7.58 |
About Biomerica, Inc.
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
- CEO
- Zackary S. Irani
- Employees
- 64
- Beta
- 0.20
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.24 ÷ $2.19) − 1 = -43.38% (DCF, example).